Login / Signup

Use of drug-coated balloons and stents in patients with femoropopliteal artery disease and severe chronic kidney disease.

Yulanka Castro-DominguezKim G SmolderenGaelle RomainJeffrey TurnerCarlos I Mena-Hurtado
Published in: Vascular medicine (London, England) (2023)
Keyphrases
  • chronic kidney disease
  • end stage renal disease
  • drug induced
  • early onset
  • adverse drug
  • emergency department
  • electronic health record